Novel Structures of the Human Papilloma Virus Genome in HNSCC
Novel Structures of the Human Papilloma Virus Genome in HNSCC
批准号:
9332364
负责人:
BRAD E. WINDLE
金额:
$22.88万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2018-08-31
关键词:
AffectAlpha CellBiological ModelsCancer PatientCellsComplexDNADNA SequenceDNA Sequence AnalysisDNA StructureDNA sequencingDataData AnalysesDevelopmentDiagnosticDiseaseDisease ManagementDisease OutcomeEpidemicEpisomeExperimental ModelsFutureGene ExpressionGene Expression ProfileGenesGenomeGenomicsGrowthHead and Neck CancerHead and Neck Squamous Cell CarcinomaHigh-Throughput RNA SequencingHumanHuman GenomeHuman PapillomavirusHuman papillomavirus 16HybridsIn VitroIncidenceIndividualMalignant NeoplasmsMediatingModelingOralOutcomePatientsPatternPerformancePublic HealthReportingResearchRiskSamplingSequence AnalysisStructureStudy modelsSurvival RateThe Cancer Genome AtlasThinkingTonsilViralViral GenomeViral Oncogenebasecancer recurrencecell immortalizationcell transformationchemoradiationhigh throughput analysishuman DNAhuman dataimmortalized cellinsightintegration sitekeratinocytemalignant oropharynx neoplasmnoveltranscriptome sequencingtumortumorigenesiswhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
We seek to understand the structure of human papillomavirus (HPV) genomes in head and neck cancers by
continuing our analysis of DNA sequence data from The Cancer Genome Atlas. We hypothesize that the
type of structure of the viral genome contributes to disease outcome. Previous studies of HPV cancers
have broadly assumed three viral genome structures; episomal, integrated, a mixture of both. We present
evidence that the situation is more complex, with the possibility of viral-host DNA episomes. This research is
critical because the incidence of HPV+ oropharyngeal cancer (OPC) is increasing and is currently considered
an epidemic; recent reports have shown that 80% of these tumors are HPV+; HPV16 is present in 90% of
these. While HPV+ OPC patients respond better to chemoradiation and have a ~60% higher 5 year survival
rate than those who are HPV negative, there is a subset of ~20% HPV+ patients that do not respond well to
therapy and/or suffer from cancer recurrence who should not receive de-escalated treatment; identifying these
individuals is a priority so that they are not under treated. The questions we are posing and will answer are:
How often does the HPV genome integrate into the human genome and excise with human DNA to
reform a new episome?
We have made several observations from our preliminary studies and one relevant to this question is that the
episomal HPV genome can integrate into the human genome and subsequently excise to form a new
episome with HPV and human DNA. This autonomously replicating molecule can therefore amplify not only
intact viral oncogenes E6 and E7 but also human genes/sequences that may contribute to cancer
development.
Is the excised HPV structure or other structures of the HPV genome in HPV+ OPC a predictor of
disease outcome?
Based on the determined structures of the HPV genome in the samples available, we will preliminarily
investigate if patients with viral-human episome-containing samples have a worse disease outcome.
Are in vitro HPV16 transformed tonsil cells a model for studying HPV+ OPC?
We have already identified hybrid viral-human DNA episomes present in some of the TCGA HPV positive
HNSCC data. We would like to model some of these structures in primary tonsil cells. We propose to first
analyze gene expression from tonsil cells transformed with HPV16 using RNA-seq. We will determine a) if
the expression of the viral genome in these cells is similar to the patterns observed in the HPV+ OPC and b)
if the host gene expression pattern is similar to that of HPV+ OPC. If the answer to these questions is yes
then further studies of these cells as a model for HPV+ OPC transformed cells would be warranted, including
transfecting into cells some of the aberrant HPV16-host genome structures reported in this application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Structures of the Human Papilloma Virus Genome in HNSCC
-
批准号:9166448
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2016
-
负责人:BRAD E. WINDLE
-
依托单位:
HTERT EXPRESSION AS A MARKER FOR EARLY CANCER DETECTION
-
批准号:6378217
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2000
-
负责人:BRAD E. WINDLE
-
依托单位:
HTERT EXPRESSION AS A MARKER FOR EARLY CANCER DETECTION
-
批准号:6317199
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2000
-
负责人:BRAD E. WINDLE
-
依托单位:
TELOMERASES AND TELOMERASE MOLECULAR BIOLOGY
-
批准号:6395754
-
项目类别:
-
资助金额:$0.71万
-
财政年份:1999
-
负责人:BRAD E. WINDLE
-
依托单位:
TELOMERASES AND TELOMERASE MOLECULAR BIOLOGY
-
批准号:6396863
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:BRAD E. WINDLE
-
依托单位:
TELOMERASES AND TELOMERASE MOLECULAR BIOLOGY
-
批准号:6269711
-
项目类别:
-
资助金额:$9.58万
-
财政年份:1998
-
负责人:BRAD E. WINDLE
-
依托单位:
TELOMERASES AND TELOMERASE MOLECULAR BIOLOGY
-
批准号:6103070
-
项目类别:
-
资助金额:$0.71万
-
财政年份:1998
-
负责人:BRAD E. WINDLE
-
依托单位:
TELOMERASES AND TELOMERASE MOLECULAR BIOLOGY
-
批准号:6237563
-
项目类别:
-
资助金额:$7.37万
-
财政年份:1997
-
负责人:BRAD E. WINDLE
-
依托单位:
EXTRACHROMOSOMAL DNA IN PATIENTS' OVARIAN CANCERS
-
批准号:2099242
-
项目类别:
-
资助金额:$11.02万
-
财政年份:1994
-
负责人:BRAD E. WINDLE
-
依托单位:
HIGH-RESOLUTION EXTENDED DNA MAPPING OF YACS
-
批准号:2209210
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1993
-
负责人:BRAD E. WINDLE
-
依托单位:
HIGH-RESOLUTION EXTENDED DNA MAPPING OF YACS
-
批准号:2209212
-
项目类别:
-
资助金额:$7.79万
-
财政年份:1993
-
负责人:BRAD E. WINDLE
-
依托单位:
EXTRACHROMOSOMAL DNA IN PATIENTS' OVARIAN CANCERS
-
批准号:3509637
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1993
-
负责人:BRAD E. WINDLE
-
依托单位:
HIGH-RESOLUTION EXTENDED DNA MAPPING OF YACS
-
批准号:2209211
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1993
-
负责人:BRAD E. WINDLE
-
依托单位:
REPAIR AND RECOMBINATION OF BROKEN CHROMOSOMES
-
批准号:3460259
-
项目类别:
-
资助金额:$9.8万
-
财政年份:1991
-
负责人:BRAD E. WINDLE
-
依托单位:
REPAIR AND RECOMBINATION OF BROKEN CHROMOSOMES
-
批准号:2096148
-
项目类别:
-
资助金额:$9.59万
-
财政年份:1991
-
负责人:BRAD E. WINDLE
-
依托单位:
REPAIR AND RECOMBINATION OF BROKEN CHROMOSOMES
-
批准号:2096149
-
项目类别:
-
资助金额:$10.12万
-
财政年份:1991
-
负责人:BRAD E. WINDLE
-
依托单位:
REPAIR AND RECOMBINATION OF BROKEN CHROMOSOMES
-
批准号:3460260
-
项目类别:
-
资助金额:$8.32万
-
财政年份:1991
-
负责人:BRAD E. WINDLE
-
依托单位:
REPAIR AND RECOMBINATION OF BROKEN CHROMOSOMES
-
批准号:3460261
-
项目类别:
-
资助金额:$8.96万
-
财政年份:1991
-
负责人:BRAD E. WINDLE
-
依托单位:
REPLICATION ORIGINS AND GENE AMPLIFICATION INTERMEDIATES
-
批准号:3033822
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1989
-
负责人:BRAD E. WINDLE
-
依托单位:
REPLICATION ORIGINS AND GENE AMPLIFICATION INTERMEDIATES
-
批准号:3033823
-
项目类别:
-
资助金额:$2.21万
-
财政年份:1989
-
负责人:BRAD E. WINDLE
-
依托单位:
海外基金